Atlas Trials

Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM

Clinical trial NCT01677299 · COMPLETED

Trial details

NCT number
NCT01677299
Sponsor
Elcelyx Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2012-05-01
Primary completion
2012-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.